8-K: Strive Reports Q4 Loss Amid Bitcoin Value Dip, Boosts Holdings

Strive, Inc. announced a significant net loss for Q4 2025, primarily due to a decrease in Bitcoin's fair value, despite successfully accumulating over 13,600 Bitcoin and raising substantial capital.

Summary

• Strive, Inc. reported financial results for the fourth quarter ended December 31, 2025, and provided updates through March 17, 2026.
• The company accumulated a total of 13,628 Bitcoin as of March 17, 2026, sourced from PIPE proceeds, the acquisition of Semler Scientific, and other capital markets activities.
• Achieved a Bitcoin Yield of 22.2% in Q4 2025 and 13.8% quarter-to-date in Q1 2026 (as of March 17, 2026).
• Generated a Bitcoin Gain of 1,305 BTC in Q4 2025 and 1,050 BTC quarter-to-date in Q1 2026.
• Reported a Bitcoin $ Gain of $114.3 million in Q4 2025 and $78.2 million quarter-to-date in Q1 2026.
• Cash and cash equivalents totaled $83.7 million as of March 17, 2026.
• GAAP net loss was $393.6 million for the period from September 12, 2025, to December 31, 2025, with $194.5 million (95.4%) attributable to the fair market value decrease in Bitcoin holdings.
• Non-GAAP adjusted net loss attributable to common stockholders was $208.2 million, or $4.73 per diluted common share, with $194.5 million (93.4%) due to the fair market value decrease in Bitcoin holdings.
• Completed a registered public offering of Variable Rate Series A Perpetual Preferred Stock (SATA Stock) on November 10, 2025, raising approximately $148.4 million net proceeds.
• Completed a follow-on registered public offering of SATA Stock on January 27, 2026, raising approximately $109.2 million net proceeds.
• Acquired Semler Scientific, Inc. in an all-stock transaction, gaining approximately 5,048 Bitcoin and establishing Clinivanta, a preventative healthcare subsidiary intended for monetization.
• Retired a $20 million loan with Coinbase Credit Inc. and exchanged $90.0 million of convertible notes using proceeds from the January 2026 offering and cash on hand.
• Made an initial investment of $50 million in STRC Stock of Strategy Inc. in March 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed but strategically active report. While significant GAAP losses due to Bitcoin's fair value decrease are a concern, the company's successful Bitcoin accumulation, substantial capital raises, and clear strategic direction in digital credit indicate strong execution of its stated business model.

Positives

• Successfully accumulated a significant total of 13,628 Bitcoin as of March 17, 2026, demonstrating execution of its core strategy.
• Achieved positive Bitcoin Yields (22.2% in Q4 2025, 13.8% QTD Q1 2026) and Bitcoin Gains (1,305 BTC in Q4 2025, 1,050 BTC QTD Q1 2026).
• Successfully raised substantial capital through two public offerings of SATA Stock, totaling approximately $257.6 million in net proceeds.
• Strategic acquisition of Semler Scientific, Inc. added 5,048 Bitcoin to holdings and created Clinivanta, a new subsidiary with monetization potential.
• Proactively retired a $20 million loan and exchanged $90.0 million of convertible notes, strengthening the balance sheet by reducing assumed debt.

Negatives

• Reported a substantial GAAP net loss of $393.6 million for the period from September 12, 2025, to December 31, 2025.
• The primary driver of the GAAP net loss was a $194.5 million fair market value decrease in Bitcoin holdings, accounting for 95.4% of the remaining loss after non-recurring and non-cash items.
• Non-GAAP adjusted net loss attributable to common stockholders was $208.2 million, with 93.4% also due to the fair market value decrease in Bitcoin.
• Incurred significant goodwill and intangible asset impairment of $140.8 million and other derivative losses of $14.7 million.

Risks

• The outcome of any legal proceedings that may be instituted against Strive or its subsidiaries.
• The possibility that the anticipated benefits of the merger transaction with Semler Scientific, Inc. are not realized as expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential dilution caused by Strive's issuance of additional shares of its Class A common stock or SATA Stock.
• Potential adverse reactions of Strive's clients and customers or changes to business or employee relationships, including those resulting from the completion of the merger transaction.

Future Outlook

Strive is focused on cementing its foundation as a structured finance company specializing in digital credit, seeing a multi-trillion dollar opportunity. The company aims to build a track record of success for its SATA digital credit product by maintaining a stable trading range and a strong balance sheet, which is expected to generate attractive long-term returns for common equity stockholders compared to its Bitcoin hurdle rate. Strive also intends to monetize Clinivanta, the operating business acquired from Semler Scientific, as it remains focused on its Bitcoin accumulation strategy.

Management Comments

• "Cementing our foundation as a structured finance company laser focused on digital credit."
• "We see a multi-trillion dollar opportunity for digital credit to scale in the years to come."
• "We believe our digital credit product, SATA, provides a liquid and scalable solution for investors targeting double-digit yield with minimal volatility."
• "Were focused on building a track record of success for SATA by maintaining a stable trading range and keeping a strong balance sheet, which we believe will generate attractive long-term returns to our common equity stockholders vs our Bitcoin hurdle rate."

Industry Context

StockSavvy.ai notes that Strive's strategy to operate as a 'bitcoin treasury company' and a 'structured finance company laser focused on digital credit' positions it uniquely at the intersection of traditional finance and the burgeoning digital asset economy. This approach differentiates it from pure-play Bitcoin miners or traditional financial institutions, aiming to leverage Bitcoin as a core asset while developing a high-yield digital credit product (SATA). The stated 'multi-trillion dollar opportunity' for digital credit reflects a bullish outlook on the expansion of decentralized finance and tokenized assets, a trend gaining traction across the broader financial industry.

Comparison to Industry Standards

• Strive's 'Bitcoin Yield' and 'Bitcoin Gain' metrics are proprietary and not directly comparable to standard financial performance indicators used by traditional companies or even most crypto-focused entities, making direct industry benchmarking challenging.
• The company's strategy of holding Bitcoin as a primary treasury asset, similar to MicroStrategy, places it in a niche category, but Strive further differentiates itself by developing a 'digital credit' product (SATA) and intending to monetize a preventative healthcare subsidiary (Clinivanta), which is a more diversified approach than pure Bitcoin corporate treasuries.
• The significant GAAP net loss driven by Bitcoin's fair value decrease is a common accounting challenge for companies holding volatile crypto assets under current accounting standards (ASU 2023-08), similar to how other crypto-asset holders might report.

Management Changes

Corporate Governance

Legal Proceedings

• The company identifies the outcome of any legal proceedings that may be instituted against Strive or its subsidiaries as a potential risk factor, but no specific ongoing proceedings are detailed in the filing.

Stakeholder Impact

• Shareholders: Face potential dilution from future stock issuances, but also benefit from the company's strategic Bitcoin accumulation and potential long-term returns from the digital credit business. The significant GAAP net loss due to Bitcoin's fair value decrease directly impacts reported earnings per share.
• Employees: The acquisition of Semler Scientific and the formation of Clinivanta may lead to organizational changes and new leadership appointments, such as Michelle Fox as CEO of Clinivanta.
• Customers: Potential adverse reactions or changes to business relationships are identified as a risk factor following the merger transaction.

Next Steps

• Strive intends to monetize Clinivanta, the operating business acquired from Semler Scientific.
• The company is focused on building a track record of success for its SATA digital credit product by maintaining a stable trading range and a strong balance sheet.

Key Dates

Recommendation

Strive, Inc. is executing a high-risk, high-reward strategy centered on Bitcoin accumulation and the development of a digital credit business. While the company successfully raised significant capital and increased its Bitcoin holdings, the reported GAAP net loss of $393.6 million, primarily due to Bitcoin's fair value decrease, presents a significant financial headwind. A seasoned investor would acknowledge the strategic execution and the potential of the digital credit market but would likely adopt a cautious 'hold' stance, awaiting more consistent financial performance and a clearer path to profitability beyond just asset accumulation, given the inherent volatility of its core asset and the early stage of its new business ventures.

Keywords

Bitcoin treasury, digital credit, crypto assets, financial results, SEC filing, ASST, SATA, Semler Scientific, Clinivanta, capital raise